These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7542000)

  • 41. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Oncogene ras P 21 expression and DNA ploidy in human bladder tumor].
    Wang Z
    Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):245-8. PubMed ID: 1806342
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The clinical significance of flow cytometric DNA measurement of paraffin specimen in bladder tumor].
    Wang Z
    Zhonghua Wai Ke Za Zhi; 1990 Aug; 28(8):505-8, 512. PubMed ID: 2086120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Image and flow cytometric analyses of DNA content in human solid tumors. A comparative study.
    Faranda A; Costa A; Canova S; Abolafio G; Silvestrini R
    Anal Quant Cytol Histol; 1997 Aug; 19(4):338-44. PubMed ID: 9267567
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytomorphologic and DNA cytometric features of hepatocellular carcinoma in fine needle aspirates.
    Sampatanukul P; Mikuz G; Israsena S; Vajarapongse K; Feichtinger H
    Acta Cytol; 1997; 41(2):435-42. PubMed ID: 9100778
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of ploidy level in bladder tumors and selected site specimens by flow cytometry.
    Jakobsen A; Mommsen S; Olsen S
    Cytometry; 1983 Sep; 4(2):170-3. PubMed ID: 6628139
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined analysis of cervical smears. Cytopathology, image cytometry and in situ hybridization.
    Multhaupt H; Bruder E; Elit L; Rothblat I; Warhol M
    Acta Cytol; 1993; 37(3):373-8. PubMed ID: 8388610
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The prognostic relevance of nuclear Feulgen DNA in transitional cell carcinoma of the urinary bladder. A long-term follow-up study.
    Fosså SD; Kaalhus O
    Eur Urol; 1985; 11(6):418-21. PubMed ID: 2417858
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DNA aneuploidy in G1-urothelial carcinomas of the urinary bladder.
    Borchers H; Planz B; Jakse G; Böcking A
    Urol Int; 1994; 52(3):145-50. PubMed ID: 8203053
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment and significance of diploid-range epithelial populations in DNA aneuploid breast carcinomas using multi-parametric flow cytometry.
    Visscher DW; Sochacki P; Ottosen S; Wykes S; Crissman JD
    Anal Cell Pathol; 1995 Jun; 8(4):267-77. PubMed ID: 7577742
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA-ploidy studies on cytological preparations from breast cancers by image analysis: comparison with Feulgen staining performed in destained Papanicolaou slides.
    Sidoni A; Cavaliere A; Alunno P; Bucciarelli E
    Cytometry; 1996 Dec; 26(4):293-7. PubMed ID: 8979029
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative DNA analysis in breast carcinomas: a comparison between image analysis and flow cytometry.
    Lee AK; Dugan J; Hamilton WM; Cook L; Heatley G; Kamat B; Silverman ML
    Mod Pathol; 1991 Mar; 4(2):178-82. PubMed ID: 2047381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative assessment of bladder cancer by nuclear texture analysis using automated high resolution image cytometry.
    Gschwendtner A; Hoffmann-Weltin Y; Mikuz G; Mairinger T
    Mod Pathol; 1999 Aug; 12(8):806-13. PubMed ID: 10463483
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinicopathological and biological features of DNA tetraploid colorectal cancers.
    Sun XF
    Cancer J; 2006; 12(6):501-6. PubMed ID: 17207320
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognosis of transitional cell bladder carcinoma. With special reference to ABH blood group isoantigen expression and DNA analysis.
    Malmström PU
    Scand J Urol Nephrol Suppl; 1988; 112():1-55. PubMed ID: 3068792
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognosis in bladder cancer. A study of cytometric, morphometric and immunohistochemical techniques.
    Vaskó J
    Scand J Urol Nephrol Suppl; 1994; 160():1-73. PubMed ID: 7529427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modification of tumor ploidy level via the choice of tissue taken as diploid reference in the digital cell image analysis of Feulgen-stained nuclei.
    Kiss R; Gasperin P; Verhest A; Pasteels JL
    Mod Pathol; 1992 Nov; 5(6):655-60. PubMed ID: 1285444
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intratumoral heterogeneity of DNA indexes in transitional cell bladder cancer: relation to tumor histology.
    Lipponen PK; Eskelinen MJ; Nordling S
    Eur Urol; 1991; 20(4):311-4. PubMed ID: 1814748
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative analysis of DNA content in polyomavirus-infected urothelial cells, urothelial dysplasia and high grade transitional cell carcinoma.
    Wojcik EM; Miller MC; Wright BC; Veltri RW; O'Dowd GJ
    Anal Quant Cytol Histol; 1997 Oct; 19(5):430-6. PubMed ID: 9349903
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular genetic methods in the diagnosis of invasive bladder cancer.
    Krause FS; Feil G; Zumbrägel A; Bichler KH
    Anticancer Res; 2000; 20(6D):5015-21. PubMed ID: 11326660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.